Xiaozhuang Bian

Title: Innovations of Xiaozhuang Bian in Chromatin Peptide Research

Introduction

Xiaozhuang Bian is a notable inventor based in Dalian, China. He has made significant contributions to the field of biotechnology, particularly in the development of chromatin peptide drug molecules. His work focuses on innovative solutions to combat hypoxia-related cellular responses.

Latest Patents

Xiaozhuang Bian holds a patent for "Chromatin peptides blocking human HIF-1α gene and modulating the downstream related genes." This invention involves chromatin peptide drug molecules that can effectively block the human cell hypoxia responsive pathway. These molecules are designed to bind specifically to the HIF-1α gene self-promoter or its downstream regulated gene promoters, which include more than 40 genes. The patented technology aims to permanently shut down molecular pathways associated with cell glycolysis reactions, immuno-inflammation reactions, or hypoxia responses. This innovative approach has the potential to halt the uncontrollable proliferation of tumor cells or chronic inflammation cells under hypoxic conditions.

Career Highlights

Xiaozhuang Bian is currently associated with Geneblue Corporation, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in cancer treatment and inflammatory diseases.

Collaborations

Xiaozhuang collaborates with esteemed colleagues, including Chengqiu Wang and Mi He, who contribute to his research endeavors. Their combined expertise enhances the development of innovative solutions in the field.

Conclusion

Xiaozhuang Bian's contributions to chromatin peptide research represent a significant advancement in biotechnology. His innovative patent has the potential to transform approaches to treating hypoxia-related conditions.